FCM
TXG icon

Flinton Capital Management’s 10x Genomics TXG Stock Holding History

Flinton Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$530K Buy
+10,506
New +$581K 0.02% 442

Other funds holding TXG

FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Flinton Capital Management's TXG Position: Q3 2019 in Review

Flinton Capital Management opened a new position in 10x Genomics (TXG) in Q3 2019: 10,506 shares worth $530K. The stake represents 0.02% of the portfolio and ranks #442 among its holdings.

92 funds tracked by Wall St. Rank hold TXG as of Q3 2019.

  • Flinton Capital Management held 10,506 shares of 10x Genomics worth $530K as of Q3 2019.
  • 10x Genomics was a new Flinton Capital Management position in Q3 2019.
  • 10x Genomics made up 0.02% of Flinton Capital Management's portfolio in Q3 2019, its #442 holding.
  • 92 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.